Filter posts

BIO’s Hans Sauer Calls for Less Confusing Patent Eligibility Standards

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, recently testified at the second of …

Licensing of Research Has Had Huge Impact on Economy & Jobs

A new report from BIO and AUTM demonstrates to enormous return on investment that ultimately …

International Panel Addresses the Changing Face of Biotechnology

We live in incredible times. AIDS is now largely treatable and preventable, cancer deaths are …

China Summit: Exploring Cross-Border Market Opportunities

Uncertainty breeds delay of innovation and volatility of markets. We are certainly seeing this play …

The Growing Wave of Biotech IPOs in China

As the biotechnology industry becomes more global, companies must evaluate and adopt various cross-border strategic …

When Intervention Stifles Innovation

Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore …

Unlocking India’s Biotech Potential

Globally, the biotechnology industry is recognized as an economic engine that provides high wage, high-skilled …

Senator Roberts is a Champion of Biotechnology Innovation

Last night, U.S. Senator Pat Roberts (R-Kan.) accepted BIO’s Lifetime Achievement Award, which recognized his …

BIO Urges USTR To Take Action on Growing IP Barriers in Overseas Markets

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  In particular, …

Making Innovative Drugs Available Globally

In order to bring innovative biopharmaceutical to the global market companies must navigate the unique …